unverified · Source version 79849 · locator unknown
"The FDA Commissioner's National Priority Voucher (CNPV) pilot program is being explored as a pathway to dramatically reduce review times for drug and biological product applications and manufacturing or efficacy supplements."
Unverified model/legacy excerpt; not proof. AI summary (separate from source): As of the refreshed FDA program page crawled during the Oct. 3-5, 2026 lookback, the contested CNPV pathway remained active, with listed 2026 approvals and awards; that weighs against treating the FDA-integrity promise as delivered.
unverified · Source version 79851 · locator unknown
"I am hoping to work with the Commissioner of the FDA to help insulate the career scientists at this gold standard agency from political pressures and ideology that is not evidence-driven."
Unverified model/legacy excerpt; not proof. AI summary (separate from source): Auchincloss used a House Energy and Commerce Health Subcommittee hearing to press FDA leadership over political pressure and the CNPV program, showing oversight effort but not enacted or completed restoration of FDA regulatory integrity.